Lymphoma Research Foundation- Postdoctoral Fellowship Grants

The Lymphoma Research Foundation's Postdoctoral Fellowship Grants support early career researchers dedicated to lymphoma research. Awarding a total of $195,000 over three years, the grant focuses on hypothesis-driven studies relevant to Hodgkin and non-Hodgkin lymphoma. Eligible projects include laboratory and clinical research, with a strong emphasis on significant contributions to understanding lymphoma's etiology, immunology, and treatment. Grantees are expected to dedicate 80% of their time to research, ensuring impactful advancements in the field.

The Lymphoma Research Foundation maintains a strong commitment to supporting early career investigators and ensuring they can build a successful career in the field of lymphoma research. The Postdoctoral Fellowship Grant is designed to support investigators at the level of advanced fellow or postdoctoral researcher in laboratory or clinic- based research with results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma, including chronic lymphocytic leukemia. Areas of research may include, but are not limited to, etiology, immunology, genetics, therapies and  transplantation. Historically, successful applications in this program have focused on basic, translational, and epidemiological research. The Postdoctoral Fellowship Grantee must spend 80 percent of their time in research during the award period.
Award Amount
The Lymphoma Research Foundation Postdoctoral Fellowship Grant provides a total of $195,000 to grantees over three years. $60,000 each year may be allocated to the PI’s salary and fringe. Incidental funds of $5,000 per year may be budgeted for research supplies or professional development expenses such as tuition, registration fees, and travel for courses and meetings. This Grant does not provide for institutional overhead.
Research Objectives and Evaluative Factors
All projects must be focused on hypothesis-driven research in lymphoma – the Foundation considers “lymphoma” to encompass all recognized lymphoma subtypes listed in the in the 5th edition WHO classification of lymphoid malignancies, including chronic lymphocytic leukemia (CLL). Projects which combine the study of lymphoma/CLL with another cancer or hematologic malignancy not included in the WHO classification of lymphoid malignancies (including myeloma and leukemias) will not be accepted. Bench, translational, and clinical research projects are all eligible. Applications will be reviewed by members of LRF’s Scientific Advisory Board (SAB). Evaluation of applications will be based on, but not be limited to the following factors:
Overall research proposal and its relevance and significance to lymphoma researchApplicant’s prior research experienceApplicant’s potential for and commitment to research career in lymphomaSponsor’s qualifications and record of success in training researchersLetters of support provided by senior facultyAssessment of program and facilities available to support the project